The overall seroprevalence of DENV, WNV and CHIKV in Iran were 5.9%, 18.8% and 1.8% between 2017 and 2018.
No proof of viral RNAs was presence in vectors.
Gilan and Hormozgan were high risk regions and the elderlies were at higher risk of infection by WNV and CHIKV.